风湿免疫科指南

订阅

MedSci主页 / 所有栏目 / 风湿免疫科指南

纤维肌痛运动干预患者实践指南 (2021 年)

2021-07-26 解放军医学院学报

纤维肌痛综合征

纤维肌痛是第三常见的肌肉骨骼相关疾患，发病率仅次于腰痛和骨关节炎。运动干预是纤维肌痛的主要治疗方法之 一，患者如何更好地进行自我运动是提高纤维肌痛康复效果的关键因素。

中文标题：

纤维肌痛运动干预患者实践指南 (2021 年)

发布机构：

发布日期：

2021-07-26

简要介绍：

纤维肌痛是第三常见的肌肉骨骼相关疾患，发病率仅次于腰痛和骨关节炎。运动干预是纤维肌痛的主要治疗方法之 一，患者如何更好地进行自我运动是提高纤维肌痛康复效果的关键因素。我们成立多学科专家和患者共同参与的纤维肌痛 运动干预患者实践指南工作组，依据《世界卫生组织指南制订手册》原则和程序，筛选纤维肌痛患者关注的运动干预相关问题，提出纤维肌痛运动干预患者实践 11 条意见。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=_纤维肌痛运动干预患者实践指南(2021年).pdf)] GetToolGuiderByIdResponse(projectId=1, id=f916e1c00216e18b, title=纤维肌痛运动干预患者实践指南 (2021 年), enTitle=, guiderFrom=解放军医学院学报, authorId=0, author=, summary=纤维肌痛是第三常见的肌肉骨骼相关疾患，发病率仅次于腰痛和骨关节炎。运动干预是纤维肌痛的主要治疗方法之 一，患者如何更好地进行自我运动是提高纤维肌痛康复效果的关键因素。, cover=https://img.medsci.cn/2021829/1630249393563_5579292.png, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Mon Jul 26 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="page" title="Page 1"> <div class="layoutArea"> <div class="column"> <p>纤维肌痛是第三常见的肌肉骨骼相关疾患，发病率仅次于腰痛和骨关节炎。运动干预是纤维肌痛的主要治疗方法之 一，患者如何更好地进行自我运动是提高纤维肌痛康复效果的关键因素。我们成立多学科专家和患者共同参与的纤维肌痛 运动干预患者实践指南工作组，依据《世界卫生组织指南制订手册》原则和程序，筛选纤维肌痛患者关注的运动干预相关问题，提出纤维肌痛运动干预患者实践 11 条意见。</p> <p>&nbsp;</p> </div> </div> </div>, tagList=[TagDto(tagId=10066, tagName=纤维肌痛综合征)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=95, categoryName=康复医学, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=9309, guiderKeyword=纤维肌痛, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5473, appHits=146, showAppHits=0, pcHits=667, showPcHits=5326, likes=1, shares=14, comments=8, approvalStatus=1, publishedTime=Mon Aug 30 09:48:22 CST 2021, publishedTimeString=2021-07-26, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Sun Aug 29 23:03:32 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 20:31:14 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=_纤维肌痛运动干预患者实践指南(2021年).pdf)])
_纤维肌痛运动干预患者实践指南(2021年).pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1190772, encodeId=b8cf1190e7255, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31e31573502, createdName=2654163384, createdTime=Mon Feb 07 17:08:55 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187891, encodeId=1087118e891db, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e241530233, createdName=502833265, createdTime=Tue Jan 25 04:05:30 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180630, encodeId=655c118063040, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c15565180, createdName=黎莫愁, createdTime=Tue Jan 04 23:08:10 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063352, encodeId=c17e106335221, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d845513044, createdName=ms1000000093272570, createdTime=Sun Oct 24 08:19:07 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060385, encodeId=5d2910603851f, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4ac5456434, createdName=ms5000002124511744, createdTime=Thu Oct 14 10:51:41 CST 2021, time=2021-10-14, status=1, ipAttribution=)]
    2022-02-07 2654163384

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1190772, encodeId=b8cf1190e7255, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31e31573502, createdName=2654163384, createdTime=Mon Feb 07 17:08:55 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187891, encodeId=1087118e891db, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e241530233, createdName=502833265, createdTime=Tue Jan 25 04:05:30 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180630, encodeId=655c118063040, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c15565180, createdName=黎莫愁, createdTime=Tue Jan 04 23:08:10 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063352, encodeId=c17e106335221, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d845513044, createdName=ms1000000093272570, createdTime=Sun Oct 24 08:19:07 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060385, encodeId=5d2910603851f, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4ac5456434, createdName=ms5000002124511744, createdTime=Thu Oct 14 10:51:41 CST 2021, time=2021-10-14, status=1, ipAttribution=)]
    2022-01-25 502833265

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1190772, encodeId=b8cf1190e7255, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31e31573502, createdName=2654163384, createdTime=Mon Feb 07 17:08:55 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187891, encodeId=1087118e891db, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e241530233, createdName=502833265, createdTime=Tue Jan 25 04:05:30 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180630, encodeId=655c118063040, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c15565180, createdName=黎莫愁, createdTime=Tue Jan 04 23:08:10 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063352, encodeId=c17e106335221, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d845513044, createdName=ms1000000093272570, createdTime=Sun Oct 24 08:19:07 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060385, encodeId=5d2910603851f, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4ac5456434, createdName=ms5000002124511744, createdTime=Thu Oct 14 10:51:41 CST 2021, time=2021-10-14, status=1, ipAttribution=)]
    2022-01-04 黎莫愁

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1190772, encodeId=b8cf1190e7255, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31e31573502, createdName=2654163384, createdTime=Mon Feb 07 17:08:55 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187891, encodeId=1087118e891db, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e241530233, createdName=502833265, createdTime=Tue Jan 25 04:05:30 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180630, encodeId=655c118063040, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c15565180, createdName=黎莫愁, createdTime=Tue Jan 04 23:08:10 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063352, encodeId=c17e106335221, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d845513044, createdName=ms1000000093272570, createdTime=Sun Oct 24 08:19:07 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060385, encodeId=5d2910603851f, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4ac5456434, createdName=ms5000002124511744, createdTime=Thu Oct 14 10:51:41 CST 2021, time=2021-10-14, status=1, ipAttribution=)]
    2021-10-24 ms1000000093272570

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1190772, encodeId=b8cf1190e7255, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31e31573502, createdName=2654163384, createdTime=Mon Feb 07 17:08:55 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187891, encodeId=1087118e891db, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e241530233, createdName=502833265, createdTime=Tue Jan 25 04:05:30 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180630, encodeId=655c118063040, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c15565180, createdName=黎莫愁, createdTime=Tue Jan 04 23:08:10 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063352, encodeId=c17e106335221, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d845513044, createdName=ms1000000093272570, createdTime=Sun Oct 24 08:19:07 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060385, encodeId=5d2910603851f, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4ac5456434, createdName=ms5000002124511744, createdTime=Thu Oct 14 10:51:41 CST 2021, time=2021-10-14, status=1, ipAttribution=)]
    2021-10-14 ms5000002124511744

    受益匪浅

    0

拓展阅读

2011 纤维肌痛综合征诊断和治疗指南

中华医学会风湿病学分会(CRA,Chinese Rheumatology Association) · 2011-08-01

2016 EULAR修订建议：纤维肌痛的管理

欧洲抗风湿病联盟(EULAR,The European League Against Rheumatism) · 2016-07-04

2021 SIR临床实践指南：纤维肌痛的诊断和治疗

意大利风湿病学学会(SIR,Italian Society of Rheumatology) · 2021-08-03

纤维肌痛临床诊疗中国专家共识

纤维肌痛临床诊疗中国专家共识编写组 · 2021-10-15

2023 SIN立场声明：纤维肌痛的临床标准和诊断评估

意大利神经病学学会(SIN,Italian Society of Neurology) · 2023-05-24

纤维肌痛诊疗中国心身-风湿专家共识(2023)

暂未更新 · 2023-12-27